Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New analysis by researchers from the University of Oxford and the University of Minnesota has identified a range of ‘win-win’ foods that both improve human health and have a low impact on the environment.

Eating more fruits, vegetables, nuts and wholegrains is a win-win for health and the environment © Shutterstock

Foods associated with improved health (whole grain cereals, fruits, vegetables, legumes, nuts and some vegetable oils high in unsaturated fats, such as olive oil) have among the lowest environmental impacts, they found. Foods with the largest negative environmental impacts—unprocessed and processed red meat—were consistently associated with the largest increases in disease risk.

The exceptions were fish, which is a healthy food but has moderate environmental impacts, and processed foods high in sugars, which can be harmful to health but have a relatively low environmental impact. Red meat (pork, beef, mutton, and goat) and processed meat had the highest environmental impacts of all foods and were also associated with the largest increases in disease risk. Other animal-source foods, such as dairy and poultry meat, had moderate environmental impacts and a small impact on disease risk compared to other foods.

Lead author Dr Michael Clark, of the Livestock, Environment and People (LEAP) project at the Oxford Martin School, and the Nuffield Department of Population Health, University of Oxford, says the findings could help consumers make better choices by equipping them with an understanding of the health and environmental impacts of different foods, and enable policymakers to issue more effective dietary guidelines.

Read more (University of Oxford website)

Similar stories

Major grant to strengthen research and benefit patients

Oxford University Hospitals (OUH) has made a grant of £11.5 million to the University of Oxford, which the University will match with other funding, to allow the development of major clinical research facilities which have the potential to support the introduction of innovative and ground-breaking treatments for patients.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Oxford joins forces with 11 universities to launch social impact investment fund

The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.

Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial

From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.